Role of cysteine and glutathione in HIV infection and other diseases associated with muscle wasting and immunological dysfunction

FASEB Journal

Volumn 11, Issue 13, 1997, Pages 1077-1089

  Dröge, Wulf ^a   Holm, Eggert ^b  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Cori cycle; Cyst(e)ine catabolism; Glutathione level; Insulin; Low CG syndrome; Plasma cystine level; Skeletal muscle

Indexed keywords

ACETYLCYSTEINE; CD4 ANTIGEN; CYSTEINE; GLUTATHIONE; INSULIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; AMINO ACID BLOOD LEVEL; ANIMAL MODEL; CANCER; CONTROLLED STUDY; CROHN DISEASE; EXERCISE; GLYCOLYSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MOUSE; MUSCLE ATROPHY; MUSCLE MASS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SEPSIS; SKELETAL MUSCLE; STARVATION; ULCERATIVE COLITIS; VIRUS INFECTION;

EID: 0038890841     PISSN: 08926638     EISSN: None     Source Type: Journal    
DOI: 10.1096/fasebj.11.13.9367343     Document Type: Review

References (91)

1. Pantaleo, G., Graziosi, C., and Fauci, A. S. (1993) The immunopathogenesis of human immunodeficiency virus infection. New Engl. J. Med. 328, 327-335
2. Dröge, W., Eck, H.-P., Näher, H., Pekar, U., and Daniel, V. (1988) Abnormal amino acid concentrations in the blood of patients with acquired immune deficiency syndrome (AIDS) may contribute to the immunological defect. Biol. Chem. Hoppe-Seyler 369, 143-148
3. Hack, V., Schmid, D., Breitkreutz, R., Stahl-Hennig, C., Drings, P., Kinscherf, R., Taut, F., Holm, E., and Dröge, W. (1997) Cystine levels, cystine flux and protein catabolism in cancer cachexia, HIV/SIV infection and senescence. FASEB J. 11, 84-92
4. Eck, H.-P., Stahl-Hennig, C., Hunsmann, G., and Dröge, W. (1991) Metabolic disorder as an early consequence of simian immunodeficiency virus infection in rhesus macaques. Lancet 338, 346-347
5. Eck, H.-P., Gmnder, H., Hartmann, M., Petzoldt, D., Daniel, V., and Dröge, W. (1989) Low concentrations of acid soluble thiol (cysteine) in the blood plasma of HIV-1 infected patients. Biol. Chem. Hoppe-Seyler 370, 101-108
6. Roederer, M., Staal, F. J. T., Osada, H., Herzenberg, L. A., and Herzenberg, L. A. (1991) CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses. Int. Immunol. 3, 933-937
7. Paolicchi, A., Tonarelli, P., Silva, S., Bandecchi, P., and Malvaldi, G. (1996) Changes of glutathione metabolism during feline immunodeficiency virus infection. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 13, 94-96
8. Buhl, R., Holroyd, K., Mastrangeli, A., Cantin, A. M., Jaffe, H. A., Wells, F. B., Saltini, C., and Crystal, R. G. (1989) Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 2, 1294-1298
9. Roth, E., Mühlbacher, F., Karner, J., Steininger, R., Schemper, M., and Funovics, J. (1985) Liver amino acids in sepsis. Surgery 97, 436-442
10. Zhang, P. C., and Pang, C. P. (1992) Plasma amino acid patterns in cancer. Clin. Chem. 38, 1198-1199
11. Aoki, T., Miyakoshi, H., Usuda, Y., and Herberman, R. B. (1993) Low NK syndrome and its relationship to chronic fatigue syndrome. Clin. Immunol. Immunopathol. 69, 253-265
12. Erikson, L.S. (1983) Splanchnic exchange of glucose, amino acids and free fatty acids in patients with chronic inflammatory disease. Gut 24, 1161-1168
13. Poli, G., Introna, M., Zanaboni, F., Peri, G., Carbonari, M., Aiuti, F., Lazzarin, A., Moroni, M., and Mantovani, A. (1985) Natural killer cells in intravenous drug abusers with lymphadenopathy syndrome. Clin. Exp. Immunol. 62, 128-135
14. Ullum, H., Gotzsche, P. C., Victor, J., Dickmeiss, E., Skinhoj, P., and Pedersen, B. K. (1995) Defective natural immunity: An early manifestation of human immunodeficiency virus infection. J. Exp. Med. 182, 789-799
15. Puente, J., Miranda, D., Gaggero, A.. Maturana, P., Godoy. G., Salazar, R., and Sepulveda, C. (1991) Immunological defects in septic shock. Deficiency of natural killer cells and T lymphocytes. Rev. Med. Chil. 119, 142-146
16. Blazar, B. A., Rodrick, M. L., O'Mahony, J. B., Wood, J., Bessey, P. Q., Wilmore, D. W., and Mannick, J. A. (1986) Suppression of natural killer cell function in humans following thermal and traumatic injury. J. Clin. Immunol. 6, 26-36
17. Brittenden, J., Heys, S. D., Ross, J., and Eremin, O. (1996) Natural killer cells and cancer. Cancer 77, 1226-1243
18. Shanahan, F., Leman, B., Deem, R., Niederlehner, A., Brogan, M., and Targan, S. (1989) Enhanced peripheral blood T cell cytotoxicity in inflammatory bowel disease. J. Clin. Immunol. 9, 55-64
19. Lozano-Polo, J. L., Echevarria-Vierna, S., Casafont-Morencos, F., Ledesma-Castaño, F., and Pons-Romero, F. (1990) Natural killer (NK) cells and interleukin-2 (IL-2) in Crohn disease. Rev. Esp. Enferm. Dig. 78, 71-75 (Engl. abstr.)
20. Fearon, D. T., and I.ocksley, R. M. (1996) The instructive role of innate immunity in the acquired immune response. Science 272, 50-54
21. Ott, M., Lembcke, B., Fischer, H., Jäger, R., Polat, H., Geier, H., Rech, M., Staszeswki, S., Helm, E. B., and Caspary, W. (1993) Early changes of body composition in human immunodeficiency virus-infected patients: tetrapolar body impedance analysis indicates significant malnutrition. Am. J. Clin. Nutr. 57, 15-19
22. Kotler, D. P., Wang, J., and Pierson, R. (1985) Body composition in patients with the acquired immunodeficiency syndrome. Am. J. Clin. Nutr. 42, 1255-1265
23. Brennan, M. F. (1977) Uncomplicated starvation versus cancer cachexia. Cancer Res. 37, 2359-2364
24. Pisters, P. W., and Pearlstone, D. B. (1993) Protein and amino acid metabolism in cancer cachexia: Investigative techniques and therapeutic interventions. Crit. Rev. Clin. Lab. Sci. 30, 223-272
25. DeWys, W. D., Begg, C., Lavin, P. T., Band, P. R., Bennett, J. M., Bertino, J. R., Cohen, M. H., Douglass, H. O., Jr., Engstrom, P. F., Ezdinli, E. Z., Horton, J., Johnson, G. J., Moertel, C. G., Oken, M. M., Perlia, C., Rosenbaum, C., Silverstein, M., N., Skeel, R. T., Sponzo, R. W., and Tormey, D. C. (1980) Prognostic effect of weight loss prior to chemotherapy in cancer patients. Am. J. Med. 69, 491-497
26. Lundsgaard, C., Hamberg, O., Thomsen, O. O., Nielsen, O. H., and Vilstrup, H. (1996) Increased hepatic urea synthesis in patients with active inflammatory bowel disease. J. Hepatol. 24, 587-593
27. Long, C. L., Crosby, F., Geiger, J. W., and Kinney, J. M. (1976) Parenteral nutrition in the septic patient: nitrogen balance, limiting plasma amino acids, and calorie to nitrogen ratios. Am. J. Clin. Nutr. 29, 380-391
28. Shaw, J. H., and Wolfe, R. R. (1987) Glucose and urea kinetics in patients with early and advanced gastrointestinal cancer: the response to glucose infusion and TPN. Surgery 101, 181-186
29. Parry-Billings, M., Blomstrand, E., McAndrew, N., and Newsholme, E. A. (1990) A communicational link between skeletal muscle, brain, and cells of the immune system. Int. J. Sports Med. 11, Suppl. 2: S122-S128
30. Janssen, G. M. E., van Kranenburg, G., and Geurten, P. (1988) Gender difference in decline of urea concentration during the first 2-3 days postmarathon. Can. J. Sport Sci. 13, 18P
31. Pedersen, B. K., Kappel, M., Klokker, M., Nielsen, H. B., and Secher, N. H. (1994) The immune system during exposure to extreme physiologic conditions. Int. J. Sports Med. 15, S116-S121
32. Heymsfield, S. B., and McManus C. B. (1985) Tissue components of weight loss in cancer patients. Cancer 55, 238-249
33. Felig, P., Owen, O. E., Wahren, J., and Cahill, G. F., Jr. (1969) Amino acid metabolism during prolonged starvation. J. Clin. Invest. 48, 584-594
34. Smith, S. R., Pozefsky, T., and Chhetri, M. K. (1974) Nitrogen and amino acid metabolism in adults with protein-calorie malnutrition. Metabolism 23, 603-618
35. Aoki, T., Muller, W. A., and Cahill, G. F. (1972) Hormonal regulation of glutamine metabolism in fasting man. Adv. Enzyme Regul. 10, 145-151
36. Fein, R., Kelsen, D. P., and Geller, N. (1985) Adenocarcinoma of the esophagus and gastroesophageal junction: prognostic factors and results of therapy. Cancer 56, 2512-2518
37. Warren, S. (1932) The immediate causes of death in cancer. Am. J. Med. Sci. 184, 610-615
38. Friedman, P.J. (1987) Is wasting itself lethal? A case-control prospective study. Nutr. Res. 7, 707-717
39. -, pH and the activity of carbonic anhydrase. Eur. J. Biochem. 152, 381-386
40. 15N]glutamine. J. Biol. Chem. 271, 31234-31242
41. Gross, A. Hack, V., Stahl-Hennig, C., and Dröge, W. (1996) Elevated hepatic γ-glutamylcysteine synthetase activity and abnormal sulfate levels in liver and muscle tissue may explain abnormal cysteine and glutathione levels in SIV-infected rhesus macaques. AIDS Res. Hum. Retroviruses 12, 1639-1641
42. Hack, V., Gross, A., Kinscherf, R., Bockstette, M., Fiers, W., Berke, G., and Dröge, W. (1996) Abnormal glutathione and sulfate levels after interleukin-6 treatment and in tumor-induced cachexia. FASEB J. 10, 1219-1226
43. Kinscherf, R., Hack, V., Fischbach, T., Friedmann, B., Weiss, C., Edler, L., Bärtsch, P., and Dröge, W. (1996) Low plasma glutamine in combination with high glutamate levels indicate risk for loss of body cell mass in healthy individuals: the effect of N-acetylcysteine. J. Mol. Med. 74, 393-400
44. Dröge W. Gross, A., Hack, V., Kinscherf, R., Schykowski, M., Bockstette, M., Mihm, S., and Gaiter, D. (1997) Role of cysteine and glutathione in HFV infection and cancer cachexia. Thera-peutic intervention with N-acetyl-cysteine (NAC). Adv. Pharmacol. 38, 581-600
45. Tayek, J. A. (1992) A review of cancer cachexia and abnormal glucose metabolism in humans with cancer. J. Am. Col. Nutr. 11, 445-456
46. Wilmore, D. W., and Aulick, L. H. (1978) Metabolic changes in burned patients. Surg. Clin. North Am. 58, 1173-1187
47. Cohen R.D., Iles, R. A., Barnett, D., Howell, M. E. O., and Strunin J M. (1971) The effect of changes in lactate uptake on the intracellular pH of the perfused rat liver. Clin. Sci. (London) 41, 159-170
48. Siegel, J. H., Cerra, F. B., Coleman, B., Giovannini, I., Shetye, M., Border, J. R., and McMenamy, R. H. (1979) Physiological and metabolic correlations in human sepsis. Surgery 86, 163-193
49. Striebel, J.-P., Saeger, H.-D., Ritz, R., Leweling, H., and Holm, E. (1986) Aminosäureaufnahme und -abgabe kolorektaler Karzinome des Menschen. Infusionstherapie 13, 92-104
50. Abumrad N. N., and Miller, B. (1983) The physiologic and nutritional significance of plasma-free amino acid levels. J. Parenter. Enterol. Nutr. 7, 163-170
51. Heslin, M.J. (1996) Insulin to impact on protein and amino acid metabolism. In Protein and Amino Acid Metabolism, in Cancer Cachexia (Pisters, P. W. T., and Brennan M. F., eds) pp. 187-199, R. G. Landes Company, Georgetown, Texas (Springer Heidelberg)
52. Cressman, D. E., Greenbaum, L. E., DeAngelis, R. A., Ciliberto, G., Furth, E. E., Poli, V., Taub, R. (1996) Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274, 1379
53. Turksen, K., Kupper, T., Degenstein, L., Williams, I., and Fuchs, E. (1992) Interleukin-6: Insights to its function in skin by overexpression in transgenic mice. Proc. Natl. Acad. Sci. USA 89, 5068-5072
54. Strassmann, G., Fong, M., Kenney, J. S., and Jacob, C. O. (1992) Evidence for the involvement of interleukin-6 in experimental cancer cachexia. J. Clin. Invest. 89, 1681-1684
55. Tracey, K. J., Wei, H., Manogue, K. R., Fong, Y., Hesse, D. G., Nguyen, H. T., Kuo, G. C., Beutler, B., Cotran, R. S., Cerami, A., and Lowry, S. (1988) Cachectin/tumor necrosis factor induces cachexia, anemia, and inflammation. J. Exp. Med. 167, 1211-1227
56. Brouckaert, P., Spriggs, D. R., Demetri, G., Kufe, D. W., and Fiers, W. (1989) Circulating interleukin-6 during a continuous infusion of tumor necrosis factor and imerferon-γ. J. Exp. Med. 169, 2257-2262
57. Bauss, F., Dröge, W., and Männel, D. N. (1987) Tumor necrosis factor mediates endotoxic effects in mice. Infect. Immun. 55, 1622-1625
58. De Haro, C., Méndez, R., and Santoyo, J. (1996) The eIF-2α kinases and the control of protein synthesis. FASEB J. 10, 1378-1387
59. Lin, T.-A Kong, X., Haystead, T. A. J., Pause, A., Belsham, G., Sonenberg, N.., and Lawrence, J. C., Jr. (1994) PHAS-I as a link between mitogen-activated protein kinase and translation initiation. Science 266, 653-656
60. Heslin, M. J., Newman, E., Wolf, R. F., Pisters, P. W. T., and Brennan, M.F. (1992) Effect of hyperinsulinemia on whole body and skeletal muscle leucine carbon kinetics in humans. Am. J. Physiol. 262, E911-E918
61. Hommes, M. J. T., Romijn, J. A., Endert, E., Schattenkerk, J. K. M. E., and Sauerwein, H. P. (1991) Insulin sensitivity and insulin clearance in human immunodeficiency virus-infected men. Metabolism 40, 651-656
62. Schmitz J E (1994) Patienten mit Sepsis. In Moderne Infuswnsth-emp,e (Hartig, W., ed) pp. 316-323, W. Zuckschwerdt Verlag München, Germany
63. Hall, J. C., Heel, K., and McCauley, R. (1996) Glutamine. Br. J. Sure. 83, 305-312
64. Newsholme, E. A., and Parry-Billings, M. (1990) Properties of glutamine release from muscle and its importance for the im-mune system.J. Parenter. Enteral. Nutr. 14, 63S-67S
65. Hannaford, M. C., Leiter, L. A., Josse, R. G., Goldstein, M. B., Marliss E. B., and Halperin, M. L. (1982) Protein wasting due to acidosis of prolonged fasting. Am. J. Physiol. 243, E251-E256
66. Luo, J.-L., Hammarqvist, F., Andersson, K., and Wernerman, J. (1996) Skeletal muscle glutathione after surgical trauma. Ann. Surg. 223, 420-427
67. Meister, A. (1995) Mitochondrial changes associated with glutathione deficiency. Biochim. Biophys. Acta 1271, 35-42
68. Marchetti, P., Decaudin, D., Macho, A., Zamzami, N., Hirsch, T., Susin, S. A., and Kroemer, G. (1997) Redox regulation of apoptosis: impact of thiol oxidation status on mitochondrial function. Eur.J. Immunol. 27, 289-296
69. Hack, V., Stütz, O., Kinscherf, R., Schykowski, M., Kellerer, M., Holm, E., and Dröge, W. (1996) Elevated venous glutamate levels in (pre)catabolic conditions result at least partly from a decreased glutamate transport activity. J. Mol. Med. 74, 337-343
70. Low, S. Y., Rennie, M.J., Taylor, P. M. (1994) Sodium-dependent glutamate transport in cultured rat myotubes increases after glutamate deprivation. FASEB J. 8, 127-131
71. Bergström, J., Fürst, P., Holmström, B. U., Vinnars, P., Askanasi, J., Elwyn, D. H., Michelsen, C. B., and Kinney, J. M. (1981) Influence of injury and nutrition on muscle water and electrolytes. Ann. Surg. 193, 810-816
72. 3- in muscle beneath the burn wound. J. Surg. Res. 33, 337-344
73. Dröge, W. (1989) Metabolische Störungen bei HIV-Infektion. In Project News, No. 2, pp. 4-5, AIDS-Zentrum des Bundesgesundheitsamtes, Berlin
74. Dröge, W., Eck, H.-P., and Mihm, S. (1992) HIV-induced cysteine deficiency and T cell dysfunction a rationale for treatment with N-acetyl-cysteine. Immunol. Today 13, 211-214
75. Olivier, R. (1995) Flow cytometry technique for assessing effects of N-acetylcysteine on apoptosis and cell viability of human immunodeficiency virus-infected lymphocytes. Methods Enzymol. 251, 270-278
76. Akerlund, B., Jarstrand, C., Lindeke, B., Sönnerborg, A., Akerblad, A.-C., and Rasool, O. (1996) Effect of N-acetylcysteine (NAC) treatment on HIV-1 infection: a double-blind placebo-controlled trial. Eur. J. Clin. Pharmacol. 50, 457-461
77. Herzenberg, L. A., De Rosa, S. C., Dubs, J. G., Roederer, M., Anderson, M. T., Ela, S. W., Deresinski, S. C., and Herzenberg, L. A. (1997) Glutathione deficiency is associated with impaired survival in HIV disease. Prof. Natl. Acad. Sci. USA In press
78. Calder, P. C. (1994) Glutamine and the immune system. Clin. Nutr. 13, 2-8
79. Rohde, T., Ullum, H., Rasmussen, J. P., Kristensen, J. H., Newsholme, E., and Pedersen, B. K. (1995) Effects of glutamine on the immune system: influence of muscular exercise and HIV infection. J. Appl. Physiol. 79, 146-150
80. Dröge, W., Eck, H.-P., Betzler, M., Schlag, P., Drings, P., and Ebert, W. (1988) Plasma glutamate concentration and lymphocyte activity. J. Cancer Res. Clin. Oncol. 114, 124-128
81. Herberman, R. B., and Ortaldo, J. R. (1981) Natural killer cells: Their role in defenses against disease. Science 214, 24-30
82. Dröge, W., Schulze-Osthoff, K., Mihm, S., Galter, D., Schenk, H., Eck, H.-P., Roth, S., and Gmünder, H. (1994) Functions of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J. 8, 1131-1138
83. Witschi, A., Junker, E., Schranz, C., Speck, R. F., and Lauterburg, B. H. (1995) Supplementation of N-acetyl-cysteine fails to increase glutathione in lymphocytes and plasma of patients with AIDS. AIDS Res. Hum. Retroviruses 11, 141-143
84. + cells. FASEB J. 8, 448-451
85. + T cell number in response to 8 wk of anaerobic training. Am. J. Physiol. 272, E788-E795
86. Rohde, T., Maclean, D. A., and Pedersen, B. K. (1996) Glutamine, lymphocyte proliferation and cytokine production. Scand. J. Immunol. 44, 648-650
87. Newsholme, E. A. (1996) The possible role of glutamine in some cells of the immune system and the possible consequence for the whole animal. Experientia 52, 455-459
88. Barbul, A. (1986) Arginine: biochemistry, physiology and therapeutic implications. J. Parenter. Enteral. Nutr. 10, 227-238
89. Daly, J. M., Reynolds, J., Thom, A., Kinsley, L., Dietrick-Gallagher, M., Shou, J., and Ruggieri, B. (1988) Immune and metabolic effects of arginine in the surgical patient. Ann. Surg. 208, 512-523
90. Park, K. G. M., Hayes, P. D., Garlick, P. J., Sewell, H., and Eremin, O. (1991) Stimulation of lymphocyte natural cytotoxicity by L-arginine. Lancet 337, 645-646
91. Kirk, S. J., Regan, M. C., and Barbul, A. (1990) Cloned murine T lymphocytes synthesize a molecule with the biological characteristics of nitric oxide. Biochem. Biophys. Res. Commun. 173, 660-665